Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Neuroblastoma in Children and Adolescents (NB90)
NCT00002802Phase 3Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jul 1990
- Modality
- Classical Binding Small Molecules, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of vindesine, ifosfamide, carboplatin in neuroblastoma, sponsored by Cincinnati Children's Hospital Medical Center. Started Jul 1990; status: completed.
02
Drugs
vindesineifosfamidecarboplatin
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00002802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002802.